HOME >> BIOLOGY >> NEWS
Ethical decision-making at bioscience companies

Pharmaceutical and biotech companies, grappling with complex ethical issues (such as stem cell and animal research), say that they are gradually formalizing systematic approaches to ethical decision-making, according to a study published in PLoS Medicine.

Jocelyn Mackie and colleagues (University of Toronto and Keck Graduate Institute of Applied Life Sciences) performed over 100 in-depth, face-to-face interviews with top managers and executives at 13 bioscience companies to learn about bioindustry ethics from their perspective.

The research represents some of the first empirical evidence of how bioscience companies are dealing with ethical issues. Mackie and colleagues' work will be discussed by delegates at the annual international convention of the Biotechnology Industry Association in Chicago April 9-12 (www.bio.org).

Company managers and executives say that they have adopted five approaches to ethical decision-making:

Ethical leadership (e.g. in larger companies, whole departments are dedicated to ethical issues)

External expertise (several companies use external consultants to provide ethics expertise not available internally) Internal ethics mechanisms (e.g. some companies now weigh candidates' ethical values when hiring)

External ethics engagement (e.g. more than half of the companies studied require business partners to match their ethical approaches) Ethics evaluation and reporting mechanisms (a few companies studied have formalized the way they evaluate and report to stakeholders on their ethical commitments).

"Because they operate near the cutting edge of scientific research and development, with processes and products that are often controversial," says Mackie, "the ethical commitment of bioscience companies is regularly called into question."

"Our analysis uncovered five interrelated approaches, each with several mechanisms, used to address e
'"/>

Contact: Andrew Hyde
ahyde@plos.org
44-122-346-3330
Public Library of Science
3-Apr-2006


Page: 1 2

Related biology news :

1. 4th International Conference on Ethical Issues in Biomedical Engineering
2. Ethical and scientific guidelines for study of captive great apes
3. Ethical paradigm: Relating embryonic stem cell use to organ donation
4. Honeybee decision-making ability rivals any department committee
5. Amid growing public concerns, bioscience firms begin formalizing ethical decision-making practices
6. Worth the wait? A neural mechanism related to impulsive decision-making
7. Put science at center of decision-making on third world development, experts tell UN
8. Perceptual decision-making hub pinpointed in human brain
9. Nottingham biosciences million pound injection
10. Lehigh receives $1.8 million from Howard Hughes Medical Institute for bioscience education
11. New frontiers in molecular bioscience topic of UD symposium

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/28/2020)... ... June 25, 2020 , ... ... biopharmaceutical R&D, today announced that it has entered into a multi-year contract ... (Multiclonics®), to support their translational and clinical research strategy to discover and ...
(Date:6/25/2020)... ... June 24, 2020 , ... ... software and software-driven clinical data services that accelerate drug development, is collaborating with ... an XPO1 inhibitor, in hospitalized patients with severe COVID-19. This is the first ...
(Date:6/23/2020)... , ... June 23, 2020 , ... ... sustainable healthcare, and Renovagen Ltd, a UK supplier and manufacturer of innovative portable ... support testing operations in the fight against the COVID-19 pandemic in Zambia. , ...
Breaking Biology News(10 mins):
(Date:5/28/2020)... (PRWEB) , ... May 28, 2020 , ... The ... and security leaders as the 2020 winners of the Women in Biometrics Awards ... sponsors IDEMIA , Biometric Update and the SIA Women in ...
(Date:5/21/2020)... ... , ... Threats to intellectual property, political pressure to lower ... wisdom that says the coronavirus pandemic will generally benefit biopharmaceutical companies, a new ... commercially weaker, dealing with delays in new product launches and with fewer resources ...
(Date:5/21/2020)... ... ... Eaton Square is pleased to announce its growth on the East Coast of ... strategy and M&A advisory firm. , This is an important step for Eaton Square ... healthcare innovators with capital and investors. , Popper and Company, founded in 2003 by ...
(Date:5/15/2020)... (PRWEB) , ... May 14, ... ... supplier of human mesenchymal stem/stromal cell (hMSC) working cell banks and hMSC ... to enable streamlined and multi-format collection of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC ...
Breaking Biology Technology:
Cached News: